DODGE & COX — METLIFE INC MET: Quarterly 13F Position History
DODGE & COX has reported METLIFE INC (MET) on 41 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2016. As of Q1 2026, the position is sized at 51,114,776 shares ($3.61B market value, 1.99% of the equity book). Quarter-over-quarter share count change: 1,137,274 (-2.2%) .
- 51,114,776Shares Held (Latest Filing)
- $3.61BReported Market Value (Latest Filing)
- 1.99%Portfolio Weight (% of 13F Equity Book)
- 1,137,274Quarter-over-Quarter Share Change
- -$509.9MQuarter-over-Quarter Value Change
- 66,743,932Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 41 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 51,114,776 | 1,137,274 | -2.2% | $3.61B | 1.99% | $70.72 |
| Q4 2025 | 52,252,050 | 1,407,614 | -2.6% | $4.12B | 2.23% | $78.94 |
| Q3 2025 | 53,659,664 | +477,783 | +0.9% | $4.42B | 2.38% | $82.37 |
| Q2 2025 | 53,181,881 | 731,296 | -1.4% | $4.28B | 2.40% | $80.42 |
| Q1 2025 | 53,913,177 | 241,377 | -0.4% | $4.33B | 2.47% | $80.29 |
| Q4 2024 | 54,154,554 | 502,027 | -0.9% | $4.43B | 2.58% | $81.88 |
| Q3 2024 | 54,656,581 | 1,696,700 | -3.0% | $4.51B | 2.55% | $82.48 |
| Q2 2024 | 56,353,281 | 155,753 | -0.3% | $3.96B | 2.37% | $70.19 |
| Q1 2024 | 56,509,034 | +3,065,843 | +5.7% | $4.19B | 2.43% | $74.11 |
| Q4 2023 | 53,443,191 | 236,825 | -0.4% | $3.53B | 2.25% | $66.13 |
| Q3 2023 | 53,680,016 | 473,683 | -0.9% | $3.38B | 2.28% | $62.91 |
| Q2 2023 | 54,153,699 | +83,945 | +0.2% | $3.06B | 2.04% | $56.53 |
| Q1 2023 | 54,069,754 | +486,544 | +0.9% | $3.13B | 2.13% | $57.94 |
| Q4 2022 | 53,583,210 | 2,232,900 | -4.0% | $3.88B | 2.66% | $72.37 |
| Q3 2022 | 55,816,110 | 1,159,125 | -2.0% | $3.39B | 2.57% | $60.78 |
| Q2 2022 | 56,975,235 | 1,457,995 | -2.5% | $3.58B | 2.48% | $62.79 |
| Q1 2022 | 58,433,230 | 291,953 | -0.5% | $4.11B | 2.50% | $70.28 |
| Q4 2021 | 58,725,183 | 2,336,756 | -3.8% | $3.67B | 2.27% | $62.49 |
| Q3 2021 | 61,061,939 | 466,976 | -0.8% | $3.77B | 2.46% | $61.73 |
| Q2 2021 | 61,528,915 | 2,982,150 | -4.6% | $3.68B | 2.41% | $59.85 |
| Q1 2021 | 64,511,065 | 1,704,848 | -2.6% | $3.92B | 2.80% | $60.79 |
| Q4 2020 | 66,215,913 | 528,019 | -0.8% | $3.11B | 2.46% | $46.95 |
| Q3 2020 | 66,743,932 | +405,961 | +0.6% | $2.48B | 2.27% | $37.17 |
| Q2 2020 | 66,337,971 | +7,276,396 | +12.3% | $2.42B | 2.23% | $36.52 |
| Q1 2020 | 59,061,575 | +12,609,032 | +27.1% | $1.81B | 1.95% | $30.57 |
| Q4 2019 | 46,452,543 | 346,175 | -0.7% | $2.37B | 1.81% | $50.97 |
| Q3 2019 | 46,798,718 | +252,497 | +0.5% | $2.21B | 1.82% | $47.16 |
| Q2 2019 | 46,546,221 | +117,038 | +0.3% | $2.31B | 1.87% | $49.67 |
| Q1 2019 | 46,429,183 | +287,300 | +0.6% | $1.98B | 1.62% | $42.57 |
| Q4 2018 | 46,141,883 | 32,829 | -0.1% | $1.89B | 1.74% | $41.06 |
| Q3 2018 | 46,174,712 | 192,600 | -0.4% | $2.16B | 1.67% | $46.72 |
| Q2 2018 | 46,367,312 | +750,425 | +1.6% | $2.02B | 1.62% | $43.60 |
| Q1 2018 | 45,616,887 | +5,918,350 | +14.9% | $2.09B | 1.69% | $45.89 |
| Q4 2017 | 39,698,537 | +16,647 | +0.0% | $2.01B | 1.55% | $50.56 |
| Q3 2017 | 39,681,890 | 954,571 | -2.3% | $2.06B | 1.66% | $51.95 |
| Q2 2017 | 40,636,461 | 175,250 | -0.4% | $2.23B | 1.88% | $54.94 |
| Q1 2017 | 40,811,711 | 269,263 | -0.7% | $2.16B | 1.83% | $52.82 |
| Q4 2016 | 41,080,974 | +28,793 | +0.1% | $2.21B | 1.97% | $53.89 |
| Q3 2016 | 41,052,181 | +1,918,855 | +4.9% | $1.82B | 1.71% | $44.43 |
| Q2 2016 | 39,133,326 | +8,185,247 | +26.4% | $1.56B | 1.54% | $39.83 |
| Q1 2016 | 30,948,079 | — | — | $1.36B | 1.33% | $43.94 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did DODGE & COX first disclose a MET position in 13F-HR filings?
DODGE & COX first reported METLIFE INC (MET) on its 13F-HR filing for the period ending 2016-03-31 (Q1 2016). The position has appeared on 41 reported quarters within Pactolio's tracked window.
What was DODGE & COX's most recent quarter-over-quarter share-count change in MET?
Between Q4 2025 and Q1 2026, DODGE & COX reduced its MET position by 1,137,274 shares (-2.2%), leaving 51,114,776 shares at a market value of $3.61B.
Does the implied price-per-share represent DODGE & COX's cost basis in MET?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.